|Patient-Centered Cancer Care
Analysis finds racial disparities in survival in kidney cancer
White patients with renal cell carcinoma were more likely to survive at least five years than their black counterparts, according to a study in the journal Cancer. A higher prevalence of localized cancer, smaller tumors and less aggressive kidney cancer among black patients, however, should point to better prognosis. Differences in surgery rates and underlying health conditions could be among the factors behind the difference, researchers said. HealthDay News
Rehabilitation program focuses on post-cancer recovery
Harvard Medical School physician Julie Silver created the Survivorship Training and Rehabilitation, or STAR, program after her battle with cancer left her debilitated and sick from the treatment. She says cancer survivors need rehab to help reduce post-cancer pain, fatigue and other effects that damage their quality of life. "The conversation should have been, 'We're going send you to cancer rehab, help you get stronger. We're gonna try to decrease some of your pain, your fatigue. We're gonna try to get you back to taking care of your kids and eventually get you back to work to take care of your patients,' " Silver says. WBUR-FM (Boston)
Informed consent documents are often murky, study finds
Informed consent documents are often less clear about risks and complications of biopsies than they are about simple blood draws, a study published in the Journal of Clinical Oncology found. Cancer trial participants are rarely made aware that biopsies are often painful and have little or no therapeutic value, the researchers found. "I think a lot of patients understandably think that when they're volunteering for these studies they're giving tissue for what is cutting-edge science, and sometimes that's true, but not always," said McGill University bioethicist Jonathan Kimmelman, who was not involved in the study. Reuters
|Emerging Trends, Products & Technologies
Pain associated with cancer can last beyond treatment. To help survivors cope with this challenge and others, the LIVESTRONG Foundation and the American Society of Clinical Oncology teamed up to create Moving Forward, a series of videos that offer help and advice for living with the aftereffects of cancer treatment. To learn more, visit the LIVESTRONG blog.
This year’s REV took place on Oct. 18 in Austin, Texas. The goal of REV, a forum created by Genentech and the LIVESTRONG Foundation, is to generate an information and idea exchange that promotes teamwork, creative thinking and groundbreaking solutions. People from all over the world came to hear industry leaders and change makers speak, and hundreds shared their experience and thoughts on Twitter. Main issues at this discussion included: improving the data and research process, increasing the patient’s voice and creating new ways to connect people to work as a team against cancer. To learn more about this year’s REV, visit the LIVESTRONG blog.
The LIVESTRONG Foundation does not necessarily endorse the opinions that
may be mentioned on this site, the articles are published for informational purposes
and are not intended to be a substitute for professional medical advice, diagnosis,
or treatment. Always seek the advice of your physician or other qualified health
provider with any questions you may have regarding a medical condition. Never
disregard professional medical advice or delay in seeking it because of something
you have read on this site.
|About the LIVESTRONG Foundation
Foundation provides free cancer
support services to help people cope with the financial, emotional and practical
challenges that accompany the disease. Created in 1997 by cancer survivor and
philanthropist Lance Armstrong, the Foundation is known for its powerful brand
–and for its advocacy
on behalf of survivors and their families. With its iconic yellow
wristband, the Foundation has
become a symbol of hope and inspiration around the world. Since its inception,
the Foundation has raised nearly $500 million to support cancer survivors and
served 2.5 million people affected by the disease. For more information, visit
Please contact one of our specialists for advertising opportunities,
editorial inquiries, job placements, or any other questions.